» Articles » PMID: 1380129

Defective Regulation of Outwardly Rectifying Cl- Channels by Protein Kinase A Corrected by Insertion of CFTR

Overview
Journal Nature
Specialty Science
Date 1992 Aug 13
PMID 1380129
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic fibrosis (CF) is a lethal genetic disease resulting in a reduced Cl- permeability, increased mucous sulphation, increased Na+ absorption and defective acidification of lysosomal vesicles. The CF gene encodes a protein (the cystic fibrosis transmembrane conductance regulator, CFTR) that can function as a low-conductance Cl- channel with a linear current-voltage relationship whose regulation is defective in CF patients. Larger conductance, outwardly rectifying Cl- channels are also defective in CF and fail to activate when exposed either to cyclic AMP-dependent protein kinase A or to protein kinase C. The role of the outwardly rectifying Cl- channel in CF has been questioned. We report here that expression of recombinant CF genes using adeno-associated virus vectors in CF bronchial epithelial cells corrects defective Cl- secretion, that it induces the appearance of small, linear conductance Cl- channels, and restores protein kinase A activation of outwardly rectifying Cl- channels. These results re-establish an involvement of outwardly rectifying Cl- channels in CF and suggest that CFTR regulates more than one conductance pathway in airway tissues.

Citing Articles

The Role of Yes-Associated Protein in Inflammatory Diseases and Cancer.

Zhong B, Du J, Liu F, Sun S MedComm (2020). 2025; 6(3):e70128.

PMID: 40066231 PMC: 11892025. DOI: 10.1002/mco2.70128.


From CFTR to a CF signalling network: a systems biology approach to study Cystic Fibrosis.

Najm M, Martignetti L, Cornet M, Kelly-Aubert M, Sermet I, Calzone L BMC Genomics. 2024; 25(1):892.

PMID: 39342081 PMC: 11438383. DOI: 10.1186/s12864-024-10752-x.


Low-intensity ultrasound activates transmembrane chloride flow through CFTR.

Wen Y, Lin M, Liu J, Tang J, Qi X Biochem Biophys Rep. 2024; 37:101604.

PMID: 38188360 PMC: 10767314. DOI: 10.1016/j.bbrep.2023.101604.


Editorial: Functional Characterization and Pharmaceutical Targets in Common and Rare CFTR Dysfunctions.

Schneider-Futschik E, Lobert V, Wilson J Front Physiol. 2022; 12:830285.

PMID: 35140634 PMC: 8819176. DOI: 10.3389/fphys.2021.830285.


Assessment of Lentiviral Vector Mediated CFTR Correction in Mice Using an Improved Rapid Nasal Potential Difference Measurement Protocol.

Cmielewski P, Delhove J, Donnelley M, Parsons D Front Pharmacol. 2021; 12:714452.

PMID: 34385926 PMC: 8353152. DOI: 10.3389/fphar.2021.714452.